Jaguar8 commented on a stock · Nov 12, 2024 19:02

NEWS

Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply

Revelation Biosciences (NASDAQ: REVB) has completed the GMP manufacture of Gemini drug product for upcoming clinical studies in the United States. This manufacturing milestone is a key requirement for FDA's Investigational New Drug (IND) application. The current Gemini supply will support both the upcoming Phase 1b clinical trial in chronic kidney disease (CKD) patients and future Phase 2 studies. The company expects to report top-line results, including pharmacokinetic, pharmacodynamic, and safety data, in the first half of 2025.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

7234 Views

Comment

Jaguar8

Spread kindness and love. Life is short. Don’t let greed eat you.

8158

Followers

Following

93K

Visitors